Business Description
Poseida Therapeutics Inc
NAICS : 325412
SIC : 2833
ISIN : US73730P1084
Share Class Description:
PSTX: Ordinary SharesDescription
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.48 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.82 | |||||
| Debt-to-EBITDA | -0.78 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -2.82 | |||||
| Beneish M-Score | -3.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29.4 | |||||
| 3-Year EPS without NRI Growth Rate | 27.6 | |||||
| 3-Year FCF Growth Rate | 33.7 | |||||
| 3-Year Book Growth Rate | -36.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.53 | |||||
| 9-Day RSI | 23.02 | |||||
| 14-Day RSI | 29.54 | |||||
| 6-1 Month Momentum % | 22.78 | |||||
| 12-1 Month Momentum % | 8.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.18 | |||||
| Quick Ratio | 3.18 | |||||
| Cash Ratio | 2.98 | |||||
| Days Sales Outstanding | 53.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.6 | |||||
| Shareholder Yield % | -5.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -200.15 | |||||
| Net Margin % | -190.76 | |||||
| FCF Margin % | -147.18 | |||||
| ROE % | -87.19 | |||||
| ROA % | -40.53 | |||||
| ROIC % | -147.38 | |||||
| ROC (Joel Greenblatt) % | -259.23 | |||||
| ROCE % | -46.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.74 | |||||
| PB Ratio | 1.87 | |||||
| Price-to-Tangible-Book | 1.96 | |||||
| EV-to-EBIT | -0.61 | |||||
| EV-to-EBITDA | -0.64 | |||||
| EV-to-Revenue | 1.08 | |||||
| EV-to-Forward-Revenue | 1.1 | |||||
| EV-to-FCF | -0.7 | |||||
| Price-to-Net-Current-Asset-Value | 3.42 | |||||
| Price-to-Net-Cash | 4.59 | |||||
| Earnings Yield (Greenblatt) % | -163.93 | |||||
| FCF Yield % | -48.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PSTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poseida Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 64.703 | ||
| EPS (TTM) ($) | -1.38 | ||
| Beta | 0.66 | ||
| Volatility % | 66.33 | ||
| 14-Day RSI | 29.54 | ||
| 14-Day ATR ($) | 0.254136 | ||
| 20-Day SMA ($) | 2.764 | ||
| 12-1 Month Momentum % | 8.58 | ||
| 52-Week Range ($) | 1.54 - 4.27 | ||
| Shares Outstanding (Mil) | 96.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Poseida Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Poseida Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Poseida Therapeutics Inc Frequently Asked Questions
What is Poseida Therapeutics Inc(PSTX)'s stock price today?
The current price of PSTX is $2.02. The 52 week high of PSTX is $4.27 and 52 week low is $1.54.
When is next earnings date of Poseida Therapeutics Inc(PSTX)?
The next earnings date of Poseida Therapeutics Inc(PSTX) is 2024-05-09 Est..
Does Poseida Therapeutics Inc(PSTX) pay dividends? If so, how much?
Poseida Therapeutics Inc(PSTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers